Vexas Syndrome Presenting As Long Covid-19
Aktuelle Rheumatologie · 01.06.2023 · 48 (03) · 212-215
DOI: 10.1055/a-1887-5341 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aktuelle Rheumatologie, erschienen am 01.06.2023. Verfasst von Derya Yildirim und 3 weiteren Autor:innen. Die Arbeit nennt 12 Literaturangaben.
Abstract (Originalsprache)
Objective
VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome is a recently described systemic inflammatory syndrome caused by somatic mutations of UBA1. COVID-19 is a viral infection that was described in 2019 and spread widely and quickly all around the world. Constitutional, thrombotic and pulmonary symptoms of these two conditions are similar, which is why cases of VEXAS syndrome may be misdiagnosed as a COVID infection. Case report We introduced a case report of a 72-year-old male patient with VEXAS syndrome who had fever, fatigue, deep vein thrombosis and a cough and was thought to have a long COVID-19 infection for one year. Then we diagnosed him with VEXAS syndrome with vacuoles in myelomonocytic cells, skin lesions and a mutation of the UBA-1 gene.
Conclusion
VEXAS and long COVID are two new conditions with overlapping clinical presentations. Physicians must be aware of these clinical conditions because of their different treatment strategy and prognosis.
Zitieren
APA
Yildirim, D., Inan, M. A., Akyurek, N., & Tufan, A. (2023). Vexas Syndrome Presenting As Long Covid-19. Aktuelle Rheumatologie, 48(03), 212-215. https://doi.org/10.1055/a-1887-5341
Vancouver
Yildirim D, Inan MA, Akyurek N, Tufan A. Vexas Syndrome Presenting As Long Covid-19. Aktuelle Rheumatologie. 2023;48(03):212-215. doi:10.1055/a-1887-5341
BibTeX
@article{Yildirim2023,
author = {Yildirim, Derya and Inan, Mehmet Arda and Akyurek, Nalan and Tufan, Abdurrahman},
title = {Vexas Syndrome Presenting As Long Covid-19},
journal = {Aktuelle Rheumatologie},
year = {2023},
volume = {48},
number = {03},
pages = {212--215},
doi = {10.1055/a-1887-5341}
}
EUVIMED